Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Ascendis Pharma A/S ASND |
FMR LLC | 5,114,369 9.067% |
-114,701 (-2.19%) |
Filing History |
| 2024-02-08 10:03 am Purchase |
2023-12-29 | 13G | Ascendis Pharma A/S ASND |
Wellington Management Group LLP | 3,248,293 5.770% |
172,281 (+5.60%) |
Filing History |
| 2024-02-02 1:18 pm Purchase |
2023-12-29 | 13G | Ascendis Pharma A/S ASND |
WESTFIELD CAPITAL MANAGEMENT CO LP | 4,030,634 7.050% |
872,466 (+27.63%) |
Filing History |
| 2023-04-10 5:00 pm Purchase |
2023-04-06 | 13G | Ascendis Pharma A/S ASND |
RA CAPITAL MANAGEMENT L.P. | 9,967,172 17.400% |
3,009,993 (+43.26%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
RA CAPITAL MANAGEMENT L.P. | 6,957,179 12.200% |
-610,721 (-8.07%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
Baker Bros. Advisors LP | 4,954,855 8.700% |
413,251 (+9.10%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
T. Rowe Price Associates, Inc. | 3,709,841 6.500% |
-1,051,352 (-22.08%) |
Filing History |
| 2023-02-14 09:33 am Purchase |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
Avoro Capital Advisors LLC | 3,100,000 5.400% |
3,100,000 (New Position) |
Filing History |
| 2023-02-10 10:01 am Purchase |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
JANUS HENDERSON GROUP PLC JHG |
3,643,955 6.400% |
423,990 (+13.17%) |
Filing History |
| 2023-02-10 09:11 am Sale |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
Artisan Partners Asset Management Inc. | 6,920,356 12.100% |
-1,020,078 (-12.85%) |
Filing History |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Ascendis Pharma A/S ASND |
FMR LLC | 5,229,070 9.271% |
-126,873 (-2.37%) |
Filing History |
| 2023-02-06 2:36 pm Sale |
2022-12-30 | 13G | Ascendis Pharma A/S ASND |
Wellington Management Group LLP | 3,076,012 5.400% |
-992,464 (-24.39%) |
Filing History |
| 2023-02-01 7:36 pm Purchase |
2022-12-30 | 13G | Ascendis Pharma A/S ASND |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,158,168 5.540% |
3,158,168 (New Position) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-12-31 | 13G | Ascendis Pharma A/S ASND |
Baker Bros. Advisors LP | 4,541,604 8.000% |
1,001,334 (+28.28%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Ascendis Pharma A/S ASND |
RA CAPITAL MANAGEMENT L.P. | 7,567,900 13.300% |
1,702,562 (+29.03%) |
Filing History |
| 2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Ascendis Pharma A/S ASND |
T. Rowe Price Associates, Inc. | 4,761,193 8.300% |
-1,857,849 (-28.07%) |
Filing History |
| 2022-02-10 2:12 pm Purchase |
2021-12-31 | 13G | Ascendis Pharma A/S ASND |
JANUS HENDERSON GROUP PLC JHG |
3,219,965 5.700% |
211,136 (+7.02%) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Ascendis Pharma A/S ASND |
FMR LLC | 5,355,943 9.496% |
-19,180 (-0.36%) |
Filing History |
| 2022-02-04 09:06 am Purchase |
2021-12-31 | 13G | Ascendis Pharma A/S ASND |
Wellington Management Group LLP | 4,068,476 7.150% |
666,918 (+19.61%) |
Filing History |
| 2022-02-04 06:09 am Purchase |
2021-12-31 | 13G | Ascendis Pharma A/S ASND |
Artisan Partners Asset Management Inc. | 7,940,434 13.900% |
2,172,907 (+37.67%) |
Filing History |